PEAK6 Investments’s Procept Biorobotics PRCT Stock Holding History

PEAK6 Investments’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$353K	Buy	+4,409	New	+$313K	﹤0.01%	2514
2024 Q1	–	Sell	-45,901	Closed	-$1.92M	–	4597
2023 Q4	$1.92M	Buy	45,901 +28,453	+163%	+$969K	0.01%	1549
2023 Q3	$572K	Sell	17,448 -1,194	-6%	-$40.7K	﹤0.01%	2279
2023 Q2	$659K	Buy	+18,642	New	+$616K	﹤0.01%	1997
2022 Q3	–	Sell	-18,642	Closed	-$659K	–	5876
2022 Q2	$659K	Buy	+18,642	New	+$678K	﹤0.01%	3515

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

PEAK6 Investments's PRCT Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Procept Biorobotics (PRCT) in Q3 2024: 4,409 shares worth $353K. The stake represents ﹤0.01% of the portfolio and ranks #2514 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in PRCT as recently as Q4 2023.

PEAK6 Investments first reported a position in PRCT in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.92M in Q4 2023. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

PEAK6 Investments held 4,409 shares of Procept Biorobotics worth $353K as of Q3 2024.
Procept Biorobotics was a new PEAK6 Investments position in Q3 2024.
Procept Biorobotics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2514 holding.
PEAK6 Investments first reported a position in Procept Biorobotics in Q2 2022 and has held it in 5 quarters since.
PEAK6 Investments's Procept Biorobotics position peaked at $1.92M in Q4 2023.
250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.